(Q34350588)

English

Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

0 references

Nagadenahalli Byrareddy Siddappa

object named as

Nagadenahalli B Siddappa

5

0 references

author name string

Karanam Balasubramanyam

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Radhika A Varier

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Mohammed Altaf

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Venkatesh Swaminathan

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Udaykumar Ranga

6

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Tapas K Kundu

7

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

language of work or name

0 references

publication date

20 September 2004

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

279

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

49

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

51163-51171

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Diversity of acetylation targets and roles in transcriptional regulation: the human immunodeficiency virus type 1 promoter as a model system

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

Histone acetylation and chromatin remodeling: which comes first?

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

Cardiac histone acetylation--therapeutic opportunities abound

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

Histone deacetylase as a therapeutic target

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

Acetylation of histones and transcription-related factors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

p300 and CBP: partners for life and death

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

The p300/CBP family: integrating signals with transcription factors and chromatin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

Activator-dependent transcription from chromatin in vitro involving targeted histone acetylation by p300.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

Histone acetyltransferases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

Acetyltransferases and tumour suppression

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein-Taybi syndrome

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

Loss of CBP acetyltransferase activity by PHD finger mutations in Rubinstein-Taybi syndrome

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

Critical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

The transcriptional co-activators CREB-binding protein (CBP) and p300 play a critical role in cardiac hypertrophy that is dependent on their histone acetyltransferase activity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

Targeted derepression of the human immunodeficiency virus type 1 long terminal repeat by pyrrole-imidazole polyamides

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

HIV-1 tat transcriptional activity is regulated by acetylation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

The histone acetyltransferase, hGCN5, interacts with and acetylates the HIV transactivator, Tat

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

Administration of HDAC inhibitors to reactivate HIV-1 expression in latent cellular reservoirs: implications for the development of therapeutic strategies

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

HATs off: selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

Small molecule modulators of histone acetyltransferase p300.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

Human TFIIIC relieves chromatin-mediated repression of RNA polymerase III transcription and contains an intrinsic histone acetyltransferase activity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

Histone acetylation-mediated regulation of genes in leukaemic cells.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

Induction of apoptosis by garcinol and curcumin through cytochrome c release and activation of caspases in human leukemia HL-60 cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

Transcriptional regulation of the mdm2 oncogene by p53 requires TRRAP acetyltransferase complexes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

hADA3 is required for p53 activity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

Inhibition of human immunodeficiency virus type-1 integrase by curcumin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

Curcumin inhibits ultraviolet light induced human immunodeficiency virus gene expression

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

Evaluation of human and simian immunodeficiency virus plaque and neutralization assays

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

Anti-human immunodeficiency virus activity of YK-FH312 (a betulinic acid derivative), a novel compound blocking viral maturation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M409024200

21 January 2018

Identifiers

10.1074/JBC.M409024200

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

release_by3sk7bp6zeyvjvltj4c2ldxia

1 reference

https://api.fatcat.wiki/v0/release/by3sk7bp6zeyvjvltj4c2ldxia

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34350588&oldid=1836728592"